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AIMS, PURPOSES AND METHODS OF WORLD HEALTH ORGANIZATION
SERUM BANKS**
The World Health Organization has recently established three Reference
Serum Banks,-one at the Institute of Epidemiology and Microbiology in
Prague, Czechoslovakia; one in the South African Institute for Medical
Research in Johannesburg, South Africa and one in the Department of
Epidemiology and Public Health in the Yale University School of Medicine
in New Haven, Connecticut, U.S.A. The program envisaged by these
banks is herein briefly describedt with particular attention to their role
in the general fields of geographic pathology and global epidemiology, and
in the utilization of new methods for gathering information on the
prevalence of certain infectious and other diseases.
The serum bank takes advantage of the fact that in a single sample of
blood one can measure today upwards of 50-100 different items which
pertain to the genotype or phenotype of the person from whom the blood
sample came. Most of the latter items pertain to the individual's health or
immunization status: his antibodies to a variety of viruses or bacteria,
various blood components such as the rheumatoid factor, blood cholesterol,
etc. If then, we were to take several hundred samples of blood, let us say
from a population such as the Puerto Rican colony in New York, we could
find out a good deal about the diseases suffered by Puerto Ricans living in
an urban environment in a temperate climate.
The main aim then for which the Reference Serum Banks have been
established by the World Health Organization can be broadly described
as the exploitation of "a new method of gathering information about
people and their health conditions within different areas and populations,"
i.e. the utilization of serologic epidemiologic methods. Previous gener-
ations of investigators have usually reconstructed the picture of common
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or rare local illnesses within a given community, city or area on the basis
of vital statistics gathered from local health departments, or from the
experiences of physicians. Such methods have proved invaluable but not
always adequate, particularly when the local medical facilities were not
adequate; so the addition of the serum survey to these other established
techniques has been a welcome innovation. Through the use of these serum
surveys one can analyze quantitatively for the presence (or absence) of a
given antibody or blood component in each and every blood sample col-
lected; and one can then document the collective findings for a given com-
munity. For instance, this serologic approach is designed to answer quickly
such questions as: what is the prevalence of positive V.D.R.L. tests among
different elements of a given population; what are the average levels of
blood lipids; or what are the differential rates of immunity to poliomyelitis
for children of various ages within such populations? These and other
questions indicate general types of information to be derived from such
studies. The extent to which such information can be related to the
local environment or to racial or socio-economic status has yet to be
adequately explored.
Another principle on which the Serum Banks have been established
is that after a collection of serum samples has once been made, some of
this collection may become available for use by many different investigators
who may have various special interests, and it therefore can be put to a
variety of purposes. This is done usually by farming out the work to
specially qualified investigators. Thus the bank at Yale has considerably
expanded its value by its use of branch laboratories in different parts of
the country and we are negotiating with others whose directors have a
special desire to work on material of this kind.*
Another important function of the bank is to conserve residual amounts
of serum for possible use in the future. Such preserved sera, which is
usually lyophilized, may become available for various purposes when the
need for new information to be derived from a given collection of serum
* The names and directors of these branch laboratories and their addresses are as
follows:
Dr. M. Albrink, Department of Medicine, Medical College, Univ. of West Virginia,
Morgantown, Va.
Dr. J. Craig, Department of Microbiology, State Univ. of New York, Down State
Medical Center, Brooklyn, N. Y.
Dr. H. Feldman, Department of Preventive Medicine, State Univ. of New York,
Upstate Medical Center, Syracuse, N. Y.
Dr. L. T. Rantz, Department of Medicine, Stanford Univ. Medical School, Palo
Alto, California.
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arises, one, two, or even three decades hence. Actually these sera may even
be used for tests as yet undiscovered. Thus the Serum Bank is indeed a
long-term project.
This brings us finally to international aspects of the Serum Banks which,
sponsored as they are by the World Health Organization, are obviously
oriented in that direction. As the United States becomes more inter-
nationally minded, it seems appropriate that we investigate those methods
which might have the mutual advantages of advancing epidemiologic
knowledge and at the same time of providing nations, whether they are
developing or not, with information regarding their own health status
or health problems. The need for this serologic survey approach would
seem to be greatest among those populations, countries or areas, which
are characterized by primitive health facilities and an existing dearth of
vital statistics. Especially does this apply to relatively inaccessible areas.
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